Blue Clay Capital Management, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 190 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.

Quarter-by-quarter ownership
Blue Clay Capital Management, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$1,748,000
-9.1%
17,125
+6.2%
1.97%
-11.9%
Q2 2016$1,923,000
+1.9%
16,125
-8.5%
2.24%
+25.6%
Q1 2016$1,887,000
-13.7%
17,625
-12.6%
1.78%
-1.8%
Q4 2015$2,187,000
+15.2%
20,175
-9.0%
1.81%
+19.8%
Q3 2015$1,899,000
-26.7%
22,175
-13.6%
1.51%
+3.1%
Q2 2015$2,591,000
-8.4%
25,675
-30.0%
1.47%
-0.5%
Q1 2015$2,828,000
+27.7%
36,675
-11.8%
1.48%
-8.8%
Q4 2014$2,214,00041,6001.62%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders